Friday, 15 March 2013 20:15
Nicotine patches in smoking cessation
The authors examined the effect of 24-hour nicotine patches in smoking cessation among over-the-counter customers in Denmark, based on a randomized double-blind placebo-controlled trial. Participants were consecutive customers to whom nicotine patches were offered as the only treatment. Forty-two pharmacies in the areas of Aarhus and Copenhagen in Denmark participated in the trial.
And 522 customers who smoked 10 or more cigarettes per day were randomized to either nicotine patches or placebo from January to March 1994. Customers with chronic diseases and pregnant or breastfeeding women were excluded from the trial.
Twenty-four-hour patches were offered free of charge during a 3-month period. Those smoking 20 or more cigarettes per day started on a dose of 21-mg/day patches. Customers who smoked less started on patches of 14 mg/day; and for all of the participants, the dose was gradually reduced to 7-mg/day patches during the study period. Smoking behavior and compliance were recorded by means of self-administered questionnaires and telephone interviews. Smoking status was recorded in intervals of 4 weeks, which was fixed to be a treatment period, and 26 weeks after inclusion. There was a significant increase in smoking cessation rates after 8 weeks of follow-up but only among smokers who started on 21-mg/day patches. There was a marked placebo effect at each time of contact during the trial, especially in those smoking fewer than 20 cigarettes per day. Although the noncompliance rate was high overall due to discontinuation in the use of patches by relapsed smokers, noncompliance among successful quitters was low. More side effects were seen in the nicotine group than in the placebo group, but none of the reported side effects were serious. It appears that regular healthy smokers who were customers of nonprescribed nicotine patches and who received 21-mg/day nicotine patches benefited from the active treatment (44.1% stopped smoking after 4 weeks)Science Articles, but almost as many stopped smoking in the placebo group (37.3% after 4 weeks). No significant differences in smoking cessation rates were seen among smokers who started with the low-dose nicotine or placebo patches.
Related items
-
Confronting the Challenge - The Invisible Battles of Cancer Treatment
The journey through cancer treatment is laden with challenges, both visible and invisible. Prof. Mererid Evans from the Velindre Cancer Centre in Cardiff and the cancer and genetics division at Cardiff University shines a light on the harsh realities of battling head and neck cancer, a journey publicly chronicled by Welsh comedian Rhod Gilbert following his diagnosis. Through their shared experiences, a new perspective on cancer treatment and its impacts is unveiled, showcasing...
-
Ligandrol
A SARM with plenty of attention surrounding it is known as Ligandrol. You may hear it called Ligandrol RAD-140 also. It has been used for a long time in medical care for those with osteoporosis and wasting disease.
-
The extraordinary therapeutic properties of CBD
The healing properties of cannabis have been known since ancient times. For this reason, it has been used for many centuries as medicine for various ailments. Cannabis, unlike marijuana, does not contain the narcotic substance THC, which is why you cannot be intoxicated with it.
-
Lose weight effectively with the help of a great app
Many people have made numerous attempts to lose weight which have ended in failure. This leads to feelings of guilt – another defeat is proof that our will is not strong enough to succeed.
-
The power of human touch – origins of body to body massage
We often turn to medicine when searching for a solution to our physical and psychological problems – and of course, it's reasonable.